temozolomide has been researched along with cycloheximide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ancheta, K; Chtchetinin, J; Cloughesy, T; Lai, A; Nghiemphu, PL; Remington, M | 1 |
| Chalmers, AJ; Morley, SJ; Smalley, S | 1 |
2 other study(ies) available for temozolomide and cycloheximide
| Article | Year |
|---|---|
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
Topics: Antineoplastic Agents, Alkylating; Blotting, Western; Cell Nucleus; Cell Proliferation; Cell Survival; Cycloheximide; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Stability; Gene Expression Regulation, Neoplastic; Glioma; Green Fluorescent Proteins; Guanine; Humans; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Genetic; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; Temozolomide; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2009 |
mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cycloheximide; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; DNA, Neoplasm; Gene Expression; Humans; Morpholines; Mutation; Neuroglia; Protein Biosynthesis; Pyrimidines; Signal Transduction; Temozolomide; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2014 |